Non-trivial uses of melatonin: Its effects on sleep, jet lag, obesity, migraine, and gastrointestinal disorders
DOI:
https://doi.org/10.12775/JEHS.2025.78.57497Keywords
melatonin, indoleamines, sleep, obesity, shift work, jet lag, safety, migraine, GERD, IBSAbstract
Introduction and aim of the study: Melatonin consumption is steadily increasing. In this literature review, the authors intended to introduce the latest scientific evidence on the influence of the sleep hormone not only on the quality of time spent in bed and jet lag, but also to consider possible other positive impacts. Its eventual effects on headaches, gastrointestinal complaints, or obesity were analyzed.
Materials and methods: The authors searched the scientific literature utilizing search engines such as Science Direct, Cochrane, PubMed, Google Scholar, and UpToDate. The literature review focused on the association of melatonin with issues such as sleep, migraines, GERD, IBS, and jet lag.
Results: Most of the articles reviewed in this study highlighted the positive effects of melatonin supplementation on sleep problems and jet lag. Furthermore, many studies report that it likewise has a beneficial impact on conditions not directly related to sleep, such as obesity, GERD, IBS, or migraine. Nevertheless, the articles emphasize the need for further research to establish treatment protocols and to select an optimal dose.
References
1. Nakagawa H, Sack RL, Lewy AJ. Sleep propensity free-runs with the temperature, melatonin and cortisol rhythms in a totally blind person. Sleep. 1992;15:330–6.
2. Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. Vol. 17, World Journal of Gastroenterology. Baishideng Publishing Group Co; 2011. p. 3888–98.
3. Mahmood D. Pleiotropic Effects of Melatonin. Vol. 69, Drug Research. Georg Thieme Verlag; 2019. p. 65–74.
4. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature’s most versatile biological signal? Vol. 273, FEBS Journal. 2006. p. 2813–38.
5. Jaworek J, Konturek SJ. Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin. World J Gastroenterol. 2014 Dec;20:16902–12.
6. Gitto E, Tan DX, Reiter RJ, Karbownik M, Manchester LC, Cuzzocrea S, et al. Individual and synergistic antioxidative actions of melatonin: studies with vitamin E, vitamin C, glutathione and desferrrioxamine (desferoxamine) in rat liver homogenates. Journal of Pharmacy and Pharmacology. 2010 Oct;53:1393–401.
7. Tan DX, Xu B, Zhou X, Reiter RJ. Pineal calcification, melatonin production, aging, associated health consequences and rejuvenation of the pineal gland. Vol. 23, Molecules. MDPI AG; 2018.
8. Vasey C, McBride J, Penta K. Circadian rhythm dysregulation and restoration: The role of melatonin. Vol. 13, Nutrients. MDPI; 2021.
9. Ishihara A, Courville AB, Chen KY. The Complex Effects of Light on Metabolism in Humans. Vol. 15, Nutrients. MDPI; 2023.
10. Hartstein LE, Garrison MM, Lewin D, Boergers J, Lebourgeois MK. Characteristics of Melatonin Use among US Children and Adolescents. Vol. 178, JAMA Pediatrics. American Medical Association; 2024. p. 91–3.
11. Li J, Somers VK, Xu H, Lopez-Jimenez F, Covassin N. Trends in Use of Melatonin Supplements among US Adults, 1999-2018. Vol. 327, JAMA. American Medical Association; 2022. p. 483–5.
12. Rivkees SA, Hao H. Developing circadian rhythmicity. Semin Perinatol. 2000;24:232–42.
13. Caba-Flores MD, Ramos-Ligonio A, Camacho-Morales A, Martínez-Valenzuela C, Viveros-Contreras R, Caba M. Breast Milk and the Importance of Chrononutrition. Vol. 9, Frontiers in Nutrition. Frontiers Media S.A.; 2022.
14. Grivas TB, Savvidou OD. Melatonin the “light of night” in human biology and adolescent idiopathic scoliosis. Scoliosis. 2007 Apr;2:6.
15. Crowley SJ, Acebo C, Carskadon MA. Human puberty: Salivary melatonin profiles in constant conditions. Dev Psychobiol. 2012 May;54:468–73.
16. Maas MB, Lizza BD, Abbott SM, Liotta EM, Gendy M, Eed J, et al. Factors Disrupting Melatonin Secretion Rhythms During Critical Illness. Crit Care Med. 2020 Jun;48:854–61.
17. Muñóz-Hoyos A, Fernández-García JM, Molina-Carballo A, Macías M, Escames G, Ruiz-Cosano C, et al. Effect of clonidine on plasma ACTH, cortisol and melatonin in children. J Pineal Res. 2000;29:48–53.
18. Kubota T, Uchiyama M, Suzuki H, Shibui K, Kim K, Tan X, et al. Effects of nocturnal bright light on saliva melatonin, core body temperature and sleep propensity rhythms in human subjects. Neurosci Res. 2002;42:115–22.
19. Minich DM, Henning M, Darley C, Fahoum M, Schuler CB, Frame J. Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Vol. 14, Nutrients. MDPI; 2022.
20. Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Vol. 269, Journal of Neurology. Springer Science and Business Media Deutschland GmbH; 2022. p. 205–16.
21. Li T, Jiang S, Han M, Yang Z, Lv J, Deng C, et al. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis. Vol. 52, Frontiers in Neuroendocrinology. Academic Press Inc.; 2019. p. 22–8.
22. Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: An American Academy of Sleep Medicine report. Sleep. 2007 Nov;30:1445–59.
23. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. Focus (Madison). 2018 Jan;16:113–8.
24. Duffy JF, Wang W, Ronda JM, Czeisler CA. High dose melatonin increases sleep duration during nighttime and daytime sleep episodes in older adults. J Pineal Res. 2022 Aug;73.
25. Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Vol. 34, Sleep Medicine Reviews. W.B. Saunders Ltd; 2017. p. 10–22.
26. Gandolfi JV, Bernardo APA Di, Chanes DAV, Martin DF, Joles VB, Amendola CP, et al. The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial. Crit Care Med. 2020 Nov;48:E1286–93.
27. Waterhouse J, Reilly T, Atkinson G. Jet-lag. Vol. 350, Lancet. Elsevier B.V.; 1997. p. 1611–6.
28. Bullock N, Martin DT, Ross A, Rosemond D, Marino FE. Effect of long haul travel on maximal sprint performance and diurnal variations in elite skeleton athletes. Br J Sports Med. 2007 Sep;41:569–73.
29. Ahmed O, Ibrahiam AT, Al-Qassab ZM, Kannan V, Ullah N, Geddada S, et al. Unraveling the Impact of Travel on Circadian Rhythm and Crafting Optimal Management Approaches: A Systematic Review. Cureus. 2024 Oct;16:e71316.
30. Drăgoi CM, Nicolae AC, Ungurianu A, Margină DM, Grădinaru D, Dumitrescu IB. Circadian Rhythms, Chrononutrition, Physical Training, and Redox Homeostasis—Molecular Mechanisms in Human Health. Vol. 13, Cells. Multidisciplinary Digital Publishing Institute (MDPI); 2024.
31. Samanta S, Ali SA. Impact of circadian clock dysfunction on human health. Exploration of Neuroscience. 2022 Sep;4–30.
32. Anderson T, Adams WM, Burns GT, Post EG, Baumann S, Clark E, et al. Addressing Circadian Disruptions in Visually Impaired Paralympic Athletes. Vol. 19, International Journal of Sports Physiology and Performance. Human Kinetics Publishers Inc.; 2024. p. 212–8.
33. Lewy AJ, Emens JS, Lefler BJ, Yuhas K, Jackman AR. Melatonin entrains free-running blind people according to a physiological dose-response curve. Chronobiol Int. 2005 Nov;22:1093–106.
34. Cengiz MI, Cengiz S, Wang HL. Melatonin and oral cavity. International Journal of Dentistry. 2012.
35. Malekpour H, Noori A, Abdi S, Abbasinazari M, Mahboubi A, Ghamsari MA. Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of Gastroesophageal Reflux Disease Symptoms: A Clinical Trial. Turkish Journal of Gastroenterology. 2023;
36. Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in gastro-esophageal reflux disease. BMC Gastroenterol. 2010 Jan;10.
37. Konturek PC, Konturek SJ, Brzozowski T. Gastric cancer and Helicobacter pylori infection. Vol. 57, Journal of Physiology and Pharmacology. 2006. p. 51–65.
38. Konturek SJ, Zayachkivska O, Havryluk XO, Brzozowski T, Sliwowski Z, Pawlik M, et al. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. Journal of Physiology and Pharmacology. 2007 Jun;58:361–77.
39. Konturek SJ, Konturek PC, Brzozowski T, Bubenik GA. Role of melatonin in upper gastrointestinal tract. Vol. 58, Journal of Physiology and Pharmacology. 2007. p. 23–52.
40. Siah KTH, Wong RKM, Ho KY. Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol. 2014 Mar;20:2492–8.
41. Oh SN, Myung SK, Jho HJ. Analgesic efficacy of melatonin: A meta-analysis of randomized, double-blind, placebo-controlled trials. J Clin Med. 2020 May;9.
42. Mozaffari S, Rahimi R, Abdollahi M. Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review. Curr Pharm Des. 2010 Dec;16:3646–55.
43. Faghih Dinevari M, Jafarzadeh F, Jabbaripour Sarmadian A, Abbasian S, Nikniaz Z, Riazi A. The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study. BMC Gastroenterol. 2023 Dec;23.
44. Ashina M. Migraine. New England Journal of Medicine. 2020 Nov;383:1866–76.
45. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.
46. Gonçalves AL, Ferreira AM, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MFP. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87:1127–32.
47. Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, et al. The association between melatonin and episodic migraine: A pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res. 2020 Sep;69.
48. Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Vol. 17, Nature Reviews Neurology. Nature Research; 2021. p. 501–14.
49. Aguilar-Shea AL, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022 Feb;54.
50. Jackson JL, Kuriyama A, Kuwatsuka Y, Nickoloff S, Storch D, Jackson W, et al. Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. PLoS One. 2019 Mar;14.
51. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017 Apr;97:553–622.
52. Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Vol. 14, Nature Reviews Neurology. Nature Publishing Group; 2018. p. 699–710.
53. Kelman L, Rains JC. Headache and sleep: Examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005 Jul;45:904–10.
54. Calhoun AH, Ford S, Finkel AG, Kahn KA, Mann JD. The prevalence and spectrum of sleep problems in women with transformed migraine. Headache. 2006 Apr;46:604–10.
55. Karsan N, Goadsby PJ. Imaging the Premonitory Phase of Migraine. Vol. 11, Frontiers in Neurology. Frontiers Media S.A.; 2020.
56. Puliappadamb H, Maiti R, Mishra A, Jena M, Mishra B. Efficacy and Safety of Melatonin as Prophylaxis for Migraine in Adults: A Meta-analysis. J Oral Facial Pain Headache. 2022 Jul;36:207–19.
57. Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis. Vol. 60, Headache. Blackwell Publishing Inc.; 2020. p. 1273–99.
58. Mehramiri A, Shalilahmadi D, Mohamadianinejad SE, Kouti L, Hosseinpour Y. The Effect of Melatonin on Reducing the Frequency and Severity of Migraine Attacks: A Double-Blind, Randomized Clinical Trial. Iran J Med Sci. 2024 May;49:313–21.
59. M.Mohamed Ali M, A. Humadi S, N. Al-Jaff A. Clinical Evaluation of Melatonin Alone and in Combination with Pizotifen in the Prophylaxis of Migraine. Iraqi Journal of Pharmaceutical Sciences ( P-ISSN: 1683 - 3597 , E-ISSN : 2521 - 3512). 2017 Mar;16:1–7.
60. Ebrahimi-Monfared M, Sharafkhah M, Abdolrazaghnejad A, Mohammadbeigi A, Faraji F. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial. Restor Neurol Neurosci. 2017;35:385–93.
61. Aguilar-Shea AL, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022 Feb;54.
62. Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: A review of current evidence from experimental and clinical studies. Vol. 51, Journal of Pineal Research. 2011. p. 270–7.
63. RETRACTION: Melatonin Prevents Oxidative Stress and Changes in Antioxidant Enzyme Expression and Activity in the Liver of Aging Rats. Vol. 76, Journal of pineal research. 2024. p. e12973.
64. Srinivasan V, Lauterbach EC, Ho KY, Acuña-Castroviejo D, Zakaria R, Brzezinski A. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol. 2012 Jun;10:167–78.
65. Mungoven TJ, Henderson LA, Meylakh N. Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives. Vol. 2, Frontiers in Pain Research. Frontiers Media S.A.; 2021.
66. Ansari M, Karkhaneh A, Kheirollahi A, Emamgholipour S, Rafiee MH. The effect of melatonin on gene expression of calcitonin gene-related peptide and some proinflammatory mediators in patients with pure menstrual migraine. Acta Neurol Belg. 2017 Sep;117:677–85.
67. Goadsby PJ, Lipton RB, Ferrari MD. Migraine — Current Understanding and Treatment. New England Journal of Medicine. 2002 Jan;346:257–70.
68. Fryar CD, Carroll MD, Ogden CL. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults Aged 20 and Over: United States, 1960–1962 Through 2013–2014 [Internet]. 2016. Available from: http://www.cdc.gov/nchs/data/databriefs/db01.pdf.
69. Carl Baker. Obesity statistics [Internet]. 2023 Jan [cited 2025 Jan 1]. Available from: https://researchbriefings.files.parliament.uk/documents/SN03336/SN03336.pdf
70. Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. New England Journal of Medicine. 2019 Dec;381:2440–50.
71. Keaver L, Xu B, Jaccard A, Webber L. Morbid obesity in the UK: A modelling projection study to 2035. Scand J Public Health. 2020 Jun;48:422–7.
72. Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012 Jun;42:563–70.
73. Hruby A, Hu FB. The Epidemiology of Obesity: A Big Picture. Vol. 33, PharmacoEconomics. Springer International Publishing; 2015. p. 673–89.
74. Agha M, Agha R. The rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y). 2017 Aug;2:e17.
75. Delpino FM, Figueiredo LM. Melatonin supplementation and anthropometric indicators of obesity: A systematic review and meta-analysis. Vols. 91–92, Nutrition. Elsevier Inc.; 2021.
76. Mostafavi SA, Akhondzadeh S, Mohammadi MR, Keshtkar AA, Hosseini S, Eshraghian MR, et al. Role of Melatonin in Body Weight: A Systematic Review and Meta-Analysis. Curr Pharm Des. 2016 Dec;23.
77. Loloei S, Sepidarkish M, Heydarian A, Tahvilian N, Khazdouz M, Heshmati J, et al. The effect of melatonin supplementation on lipid profile and anthropometric indices: A systematic review and meta-analysis of clinical trials. Vol. 13, Diabetes and Metabolic Syndrome: Clinical Research and Reviews. Elsevier Ltd; 2019. p. 1901–10.
78. Genario R, Cipolla-Neto J, Bueno AA, Santos HO. Melatonin supplementation in the management of obesity and obesity-associated disorders: A review of physiological mechanisms and clinical applications. Vol. 163, Pharmacological Research. Academic Press; 2021.
79. Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ. The Safety of Melatonin in Humans. Vol. 36, Clinical Drug Investigation. Springer International Publishing; 2016. p. 169–75.
80. Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Vol. 42, Complementary Therapies in Medicine. Churchill Livingstone; 2019. p. 65–81.
81. Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. Vol. 33, CNS Drugs. Adis; 2019. p. 1167–86.
82. Russcher M, Koch BCP, Nagtegaal JE, van Ittersum FJ, Pasker-de Jong PCM, Hagen EC, et al. Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): A randomized controlled trial. Br J Clin Pharmacol. 2013 Nov;76:668–79.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jakub Wirkijowski, Małgorzata Wirkijowska, Jolanta Mędyk, Yauheniya Patarocha, Michał Rogulski , Aleksandra Ślusarska , Paulina Błasiak , Patryk Mikołajec, Ruslan Huk, Barbara Bilecka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 186
Number of citations: 0
